T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Arrow Electronics
ARW
$10.6B
| $1.38M | ﹤0.01% |
24,675
-1,400
| -5% | -$85.1K |
|
1652
Webster Financial
WBS
$12.8B
| $1.38M | ﹤0.01% |
34,813
| – | – |
|
1653
Charles River Laboratories
CRL
$13.5B
| $1.37M | ﹤0.01% |
19,531
+5,130
| +36% | +$380K |
|
|
ALR
1654
DELISTED
Alere Inc
ALR
| $1.37M | ﹤0.01% |
25,940
| – | – |
|
1655
W.R. Berkley
WRB
$26.2B
| $1.36M | ﹤0.01% |
88,455
-4,725
| -5% | -$70.4K |
|
1656
Cracker Barrel
CBRL
$1.31B
| $1.34M | ﹤0.01% |
9,000
-1,000
| -10% | -$142K |
|
|
APOL
1657
DELISTED
Apollo Education Group Inc Class A
APOL
| $1.32M | ﹤0.01% |
102,450
-1,341,540
| -93% | -$22.7M |
|
|
SVC
1658
Service Properties Trust
SVC
$1.06B
| $1.32M | ﹤0.01% |
9,194
| – | – |
|
|
IMI
1659
DELISTED
Intermolecular, Inc.
IMI
| $1.31M | ﹤0.01% |
663,000
| – | – |
|
1660
Owens Corning
OC
$12.3B
| $1.3M | ﹤0.01% |
31,600
+300
| +1% | +$12.3K |
|
|
RGLS
1661
DELISTED
Regulus Therapeutics
RGLS
| $1.29M | ﹤0.01% |
983
+173
| +21% | +$279K |
|
|
NSM
1662
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.29M | ﹤0.01% |
76,600
+25,500
| +50% | +$553K |
|
1663
Jabil
JBL
$38.7B
| $1.28M | ﹤0.01% |
60,300
| – | – |
|
|
TWO
1664
Two Harbors Investment
TWO
$1.26B
| $1.28M | ﹤0.01% |
16,438
| – | – |
|
|
LPT
1665
DELISTED
Liberty Property Trust
LPT
| $1.27M | ﹤0.01% |
39,333
| – | – |
|
|
IM
1666
DELISTED
Ingram Micro
IM
| $1.27M | ﹤0.01% |
50,611
+42
| +0.1% | +$1.1K |
|
1667
MSC Industrial Direct
MSM
$6.75B
| $1.25M | ﹤0.01% |
17,900
+4,900
| +38% | +$349K |
|
1668
Enbridge
ENB
$112B
| $1.25M | ﹤0.01% |
26,600
+1,200
| +5% | +$59.6K |
|
1669
iShare MSCI Eurozone ETF
EZU
$9.95B
| $1.24M | ﹤0.01% |
33,100
-38,300
| -54% | -$1.51M |
|
|
RDC
1670
DELISTED
Rowan Companies Plc
RDC
| $1.24M | ﹤0.01% |
58,700
+8,900
| +18% | +$188K |
|
1671
Celldex Therapeutics
CLDX
$3.4B
| $1.24M | ﹤0.01% |
3,272
+237
| +8% | +$94.1K |
|
1672
NNN REIT
NNN
$8.87B
| $1.24M | ﹤0.01% |
35,330
| – | – |
|
1673
Suncor Energy
SU
$76.2B
| $1.23M | ﹤0.01% |
44,800
| – | – |
|
|
TUP
1674
DELISTED
Tupperware Brands Corporation
TUP
| $1.23M | ﹤0.01% |
19,120
+2,500
| +15% | +$168K |
|
1675
Cullen/Frost Bankers
CFR
$10.5B
| $1.22M | ﹤0.01% |
15,550
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.